KNSA
Kiniksa Pharmaceuticals International, plc
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Kiniksa Pharmaceuticals International, plc
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
Kiniksa Pharmaceuticals International, plc
92.18
No thesis.
Fund move
Fund move
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | FMRFMR | $445.8M | 14.72% | +2.16% | |
| 2 | Rubric Capital ManagementRubric | $255.8M | 8.45% | +6.66% | |
| 3 | Baker Bros. AdvisorsBaker Bros. | $181.3M | 5.99% | +0.30% | |
| 4 | BlackRockBlackRockindex-like | $175.2M | 5.79% | +462.85% | |
| 5 | Tang Capital ManagementTang | $144.5M | 4.77% | 0.00% | |
| 6 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $122.2M | 4.04% | +8.21% | |
| 7 | Vanguard Capital ManagementVanguardindex-like | $87.0M | 2.87% | +2.08% | |
| 8 | Morgan StanleyMorgan Stanley | $64.7M | 2.14% | +1.34% | |
| 9 | Arrowstreet Capital, Limited PartnershipArrowstreet Capital, Limited Partnership | $61.2M | 2.02% | +7.26% | |
| 10 | Spruce Street CapitalSpruce Street Capital | $58.7M | 1.94% | +20.63% | |
| 11 | Dimensional Fund AdvisorsDimensional | $55.9M | 1.85% | +7.74% | |
| 12 | InvescoInvesco | $49.4M | 1.63% | +2694.35% | |
| 13 | Driehaus Capital ManagementDriehaus | $45.9M | 1.52% | +17.47% | |
| 14 | State StreetState Streetindex-like | $45.0M | 1.49% | +818.92% | |
| 15 | Acadian Asset ManagementAcadian | $43.4M | 1.43% | −49.18% | |
| 16 | Point72 Asset ManagementPoint72 | $42.2M | 1.39% | +2.89% | |
| 17 | Rice Hall James & AssociatesRice Hall James & | $40.0M | 1.32% | +2.71% | |
| 18 | Pictet Asset Management HoldingPictet | $38.9M | 1.29% | −2.35% | |
| 19 | Geode Capital ManagementGeodeindex-like | $38.6M | 1.28% | +1263.22% | |
| 20 | Jupiter TopcoJupiter Topco | $37.5M | 1.24% | — | |
| 21 | Connor, Clark & Lunn Investment ManagementConnor, Clark & Lunn | $36.6M | 1.21% | −11.86% | |
| 22 | D. E. ShawD. E. Shaw | $36.4M | 1.20% | −40.60% | |
| 23 | Two Sigma InvestmentsTwo Sigma | $35.9M | 1.19% | +33.40% | |
| 24 | AlliancebernsteinAlliancebernstein | $35.6M | 1.17% | −7.14% | |
| 25 | Victory Capital ManagementVictory | $32.3M | 1.07% | −0.33% |
266 managers report $3.0B of Kiniksa Pharmaceuticals International on form 13F for the quarter ended Jun 30 '26. 33 of them hold 80% of it; FMR is largest at 14.72%.
Linked news
Expected move
Inputsspot 92.24exp Jan 15ATM strike 90ATM straddle 20.75IV 62%